Exact Mass: 386.30320820000003
Exact Mass Matches: 386.30320820000003
Found 408 metabolites which its exact mass value is equals to given mass value 386.30320820000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Testosterone Isocaproate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Luffariellolide
8Z,11Z,14Z,17Z,20Z-hexacosapentaenoic acid
A very long-chain omega-6 fatty acid that is hexacosanoic acid containing five double bonds located at positions 8, 11, 14, 17 and 20 (the 8Z,11Z,14Z,17Z,20Z-isomer).
1-Phenyl-1,3-eicosanedione
1-Phenyl-1,3-eicosanedione is found in fats and oils. 1-Phenyl-1,3-eicosanedione is a constituent of the pollen of Helianthus annuus (sunflower). Constituent of the pollen of Helianthus annuus (sunflower). 1-Phenyl-1,3-eicosanedione is found in fats and oils.
Mangalkanyl glucoside
Mangalkanyl glucoside is found in fruits. Mangalkanyl glucoside is a constituent of the root bark of Mangifera indica (mango) Constituent of the root bark of Mangifera indica (mango). Mangalkanyl glucoside is found in fruits.
Cryptomeridiol 11-rhamnoside
Cryptomeridiol 11-rhamnoside is a constituent of fruits of Cananga odorata (ylang ylang). Constituent of fruits of Cananga odorata (ylang ylang)
MG(20:0/0:0/0:0)
MG(20:0/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(20:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(20:0/0:0/0:0) is made up of one eicosanoyl(R1).
MG(i-20:0/0:0/0:0)
MG(i-20:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(i-20:0/0:0/0:0) is made up of one 18-methylnonadecanoyl(R1).
DG(O-18:0/2:0/0:0)
2-Acetyl-1-octadecyl-sn-glycerol, or DG(O-18:0/2:0/0:0), is an intermediate in ether lipid metabolism. 2-Acetyl-1-octadecyl-sn-glycerol is converted from 1-octadecyl-glycerone-3-phosphate. This is an ether lipid with a structure similar to platelet-activating factor which has an acetyl group instead of an acyl chain at the second position (SN-2). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.
MG(0:0/20:0/0:0)
MG(0:0/20:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(0:0/20:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/20:0/0:0) is made up of one eicosanoyl(R2).
Glycerol trihexanoate
Glycerol trihexanoate is a probable constituent of fat Probable constituent of fats.
MG(0:0/i-20:0/0:0)
MG(0:0/i-20:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/i-20:0/0:0) is made up of one 18-methylnonadecanoyl(R2).
N-Lauroyl Tryptophan
N-lauroyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Dexanabinol
Ophiobolin C
A sesterterpenoid that is ophiobolane with a hydroxy group at position 3, oxo group at positions 5, formyl group at position 7, and double bonds at positions 7-8 and 19-20.
(3beta,20S)-3-Hydroxy-4,4,14-trimethylpregna-7,9(11)-diene-20-carboxylic acid|3beta-hydroxy-4,4,14alpha-trimethyl-5alpha-pregna-7,9(11)-diene-20S-carboxylic acid
N-(3-hydroxyisotetradecanoyl)anatabine
C24H38N2O2 (386.29331279999997)
(1R,2R,4R)-4-isobutyl-6,6,8,8-tetramethyl-2,3,4,8-tetrahydrochromene-5,7-dione-2-spiro-2-6,6-dimethyl-bicyclo[3.1.1]heptane|ficifolidione
(20S)-20-(N,N-dimethylamino)-3beta-(N-acetylamido)-5alpha-pregn-16-ene|16-dehydrosarcorine
4-(1-methoxyethyl)-5-methyl-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzene-1,3-diol
20-(N,N-dimethylamino)-3beta-(N-formylamino)-5alpha-pregn-2-en-4-one|hookerianamide H
C24H38N2O2 (386.29331279999997)
(22E)-24-norcholesta-7,22-diene-3beta,5alpha,6beta-triol
3,17-dimethyl-18,19-dinor-17alpha-stigmasta-1,3,5,7,9,11,13-heptaene
Bourgeanic-Acid|Bourgeanic-saeure|xanthoric acid B
3-(4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraenyl)thiophene-1-oxide
15,16-dihydroxy-9Z,12Z-octadecadienoic acid 2,3-dihydroxypropyl ester
24,25,26,27-tetranor-23-hydroxycycloartan-3-one|macrostachyoside B
(+)-17-hydroxyemericella-3E,7E,12Z,22-tetraen-16-oic acid|emericellene C
3-oxo-24,25,26,27,29-pentnor-5alpha-cycloart-23,21-olide|aphagrandinoid C
(+)-emericella-3E,7E,22-trien-17alpha-al-16-oic acid|emericellene D
(+)-12beta,17-epoxyemericella-3E,7E,22-trien-16-oic acid|emericellene B
(20S)-3beta-N-methyl-20-(N-acetyl-N-methylamino)-5alpha-pregn-14-ene
(20R,24R)-4,17beta-Dimethyl-18,19-dinorstigmast-1,3,5,7,9,11,13-heptaene
12-deacetoxy-12-oxo-deoxoscalarin|12-deacetoxy-12-oxodeoxoscalarin|12-ketodeoxoscalarin
Cyclobuxine
Cyclobuxine D is a steroid alkaloid. Cyclobuxine D is a natural product found in Buxus wallichiana and Buxus sempervirens with data available.
(5Z,7E)-2-oxa-9,10-seco-5,7,10(19)-cholestatrien-25-ol
3-Fluoro-9,10-secocholesta-5,7,10(19)-triene
HU-211
Tricaproin
A triglyceride obtained by condensation of each of the three hydroxy groups of glycerol with hexanoic (caproic) acid.
Cryptomeridiol 11-rhamnoside
hu-210
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D020011 - Protective Agents
lyso-ornithine lipid
C21H42N2O4 (386.31444120000003)
alpha-N-(3-hydroxy-14-methyl-pentadecanoyl)-ornithine
C21H42N2O4 (386.31444120000003)
ascr#25
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,14R)-14-hydroxypentadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#25
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-15-hydroxypentadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
3-hydroxy-4-methylene-2-(n-eicos-11-yn-19-enyl)but-2-enolide
2-ethyl-2-[[(1-oxopentyl)oxy]methyl]propane-1,3-diyl divalerate
2,5-Dihexyl-1,4-benzene-diboronic acid ethylene glycol ester
C22H36B2O4 (386.27995560000005)
1,1,4,4,7,7,10,10-OCTAMETHYL-2,3,4,7,8,9,10,12-OCTAHYDRO-1H-DIBENZO[B,H]FLUORENE
2-(2-aminoethylamino)ethanol,(Z)-octadec-9-enoic acid
N,N-bis(2-ethylhexyl)-4-methyl-1H-benzotriazole-1-methylamine
1-(DODECYLOXY)-4-((4-ETHYNYLPHENYL)ETHYNYL)BENZENE
hookerianamide H
C24H38N2O2 (386.29331279999997)
A steroid alkaloid that is 5alpha-pregn-2-ene-4-one substituted by a N-formylamino group at position 3 and a N,N-dimethylamino group at position 20. Isolated from Sarcococca hookeriana, it exhibits antiplasmodial activity and inhibitory activity against cholinesterase.
(2E,14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadec-2-enoic acid
(2E)-15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadec-2-enoic acid
Octadecanoic acid, 2-[(trimethylsilyl)oxy]-, methyl ester
C22H46O3Si (386.32160459999994)
Dexanabinol
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents
DG(O-18:0/2:0/0:0)
2-Acetyl-1-octadecyl-sn-glycerol, or DG(O-18:0/2:0/0:0), is an intermediate in ether lipid metabolism. 2-Acetyl-1-octadecyl-sn-glycerol is converted from 1-octadecyl-glycerone-3-phosphate. This is an ether lipid with a structure similar to platelet-activating factor which has an acetyl group instead of an acyl chain at the second position (SN-2). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. 2-Acetyl-1-octadecyl-sn-glycerol is an intermediate in ether lipid metabolism. 2-Acetyl-1-octadecyl-sn-glycerol is converted from 1-octadecyl-glycerone-3-phosphate. This is an ether lipid with a structure similar to platelet-activating factor which has an acetyl group instead of an acyl chain at the second position (SN-2). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. [HMDB]
MG(i-20:0/0:0/0:0)
MG(i-20:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(i-20:0/0:0/0:0) is made up of one 18-methylnonadecanoyl(R1).
(3-Carboxy-2-pentadecanoyloxypropyl)-trimethylazanium
C22H44NO4+ (386.32701640000005)
[(2R)-3-carboxy-2-[(Z)-3-hydroxytetradec-5-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-Carboxy-2-(3-oxotetradecanoyloxy)propyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-Carboxy-2-(13-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(11-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(10-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(8-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(9-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(7-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(3-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(4-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(5-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(6-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-Carboxy-2-(12-methyltetradecanoyloxy)propyl]-trimethylazanium
C22H44NO4+ (386.32701640000005)
[3-carboxy-2-[(E)-12-carboxydodec-8-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-10-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-11-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-6-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-12-carboxydodec-9-enoyl]oxypropyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
[3-carboxy-2-[(E)-9-hydroxytetradec-6-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-10-hydroxytetradec-12-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-5-hydroxytetradec-3-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-8-hydroxytetradec-5-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[3-carboxy-2-[(E)-4-hydroxytetradec-2-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[(E)-2-(carboxymethyl)-2,16-dihydroxy-3-oxohexadec-4-enyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
(10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c][1]benzopyran-1-ol
1-[2-(4-methylphenyl)ethyl]-N-[3-(4-methyl-1-piperazinyl)propyl]-5-oxo-3-pyrrolidinecarboxamide
1-Cyclohexyl-4-[1-[1-[(4-fluorophenyl)methyl]-5-tetrazolyl]propyl]piperazine
C21H31FN6 (386.25940979999996)
N-[[(2R,3S,4S)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methylpropyl)propanamide
N-[[(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2S,3R,4R)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methylpropyl)propanamide
N-[[(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-methoxy-N-propan-2-ylacetamide
(3R,22R)-3,22-dihydroxytricosanoic acid
A dihydroxy monocarboxylic acid that is tricosanoic acid in which the pro-R hydrogens at positions 3 and 22 are replaced by hydroxy groups.
Pentadecanoyl-L-carnitine (chloride)
C22H44NO4+ (386.32701640000005)
(3R)-3,22-dihydroxytricosanoic acid
A dihydroxy monocarboxylic acid that is tricosanoic acid in which the pro-R hydrogen at position 3 and and one of the hydrogens of the terminal methyl group are replaced by hydroxy groups.
[3-carboxy-2-[(Z)-3-hydroxytetradec-9-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
[(1S)-3-carboxy-1-[(Z)-3-hydroxytetradec-5-enoyl]oxypropyl]-trimethylazanium
C21H40NO5+ (386.29063300000007)
(1-Hydroxy-3-propanoyloxypropan-2-yl) hexadecanoate
(1-Butanoyloxy-3-hydroxypropan-2-yl) pentadecanoate
(1-Hydroxy-3-pentanoyloxypropan-2-yl) tetradecanoate
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
C20H36NO6+ (386.25424960000004)
1-icosanoylglycerol
A 1-monoglyceride resulting from the formal condensation of the carboxy group of icosanoic acid with one of the primary hydroxy groups of glycerol.
(11Z,14Z,17Z,20Z,23Z)-hexacosapentaenoic acid
A very long-chain omega-3 fatty acid that is hexacosanoic acid having five double bonds located at positions 11, 14, 17, 20, 23 (the 11Z,14Z,17Z,20Z,23Z-isomer).
TG(18:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
DG(20:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
10-hydroxy-16-isopropyl-1,5,9,13-tetramethyl-6-oxapentacyclo[10.7.0.0²,⁹.0⁵,⁷.0¹³,¹⁷]nonadec-17-en-8-one
(6e,8e,11e,14e)-4,6,8,10,12,14,16-heptamethyloctadeca-6,8,11,14-tetraene-3,5,13-trione
(2s,3r,4r,5r,6s)-2-({2-[(2r,4ar,8r,8ar)-8-hydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
(1's,2r,4's,5'r,9's,10'r,13'r)-5',9'-dimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-5'-ylmethyl (2z)-2-methylbut-2-enoate
5-(hydroxymethyl)-3-(icos-15-en-11,13-diyn-1-yl)oxolan-2-one
4-hydroxy-4,6-dimethyl-6-(12-phenyldodec-10-en-1-yl)oxan-2-one
(1r,3s,4r,6r,7s,11s,12r)-4,6-dihydroxy-1,4-dimethyl-12-[(2s)-6-methylhepta-3,5-dien-2-yl]tricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(4r)-4-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-hydroxy-7,7,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]pentanal
(5as,5br,7as,11as,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-1-one
(2s,3s,3ar,5as,9as,9br)-3-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
(1r,4s,6r,9r,10s,13r,15r)-6-hydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl (2z)-2-methylbut-2-enoate
(4s,6e,8e,10s,11e,14e,16s)-4,6,8,10,12,14,16-heptamethyloctadeca-6,8,11,14-tetraene-3,5,13-trione
(1r,5as,5br,7as,11as,11br,13as,13bs)-1-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-chryseno[1,2-c]furan-13-one
(1s,2r,4r,5s,11s,14s,17r,18s)-11-(hydroxymethyl)-17-isopropyl-4,14-dimethylpentacyclo[9.7.0.0²,⁴.0⁵,⁹.0¹⁴,¹⁸]octadec-8-ene-8-carboxylic acid
(8as,9r,10as)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
n-{1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}carboximidic acid
C24H38N2O2 (386.29331279999997)
(5as,5br,7as,11as,11br,13r,13as,13br)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-3-one
(1s,3r,6s,8r,11s,12r,14r,15s,16r)-12,16-dimethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
(1s,4r,5r,9r,10r,13s,15r)-5,9-dimethyl-15-{[(2z)-2-methylbut-2-en-1-yl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
5-(hydroxymethyl)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl 2-methylbut-2-enoate
n-[(3as,3br,5as,7s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]ethanimidic acid
(4s,5as,5br,7as,11as,11br,13r,13as)-5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-4,13-diol
(1s,3r,8r,11s,12s,15r,16r)-15-[(2r)-4-hydroxybutan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-one
12-formyl-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7-diene-15-carboxylic acid
(4s,5as,5br,7as,11as,11br,13s,13ar)-5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-b]furan-4,13-diol
5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-4,13-diol
(1s,3r,6r,8r,11r,12r,14r,15s,16r)-12,16-dimethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
(2s,3r,4r,5r,6r)-2-ethyl-2-hydroxy-6-isopropyl-3,5-dimethyloxan-4-yl (2s,3s,4r)-3-hydroxy-2,4-dimethyl-5-oxoheptanoate
6-hydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl 2-methylbut-2-enoate
6-[4-(2-acetyl-5-methylcyclopent-2-en-1-yl)butan-2-yl]-3-isopropyl-7a-methyl-hexahydroindene-2,5-dione
(1r,4s,5r,9r,10s,13r,16s)-5-(hydroxymethyl)-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl (2e)-2-methylbut-2-enoate
(1r,3s,4r,7s,8e,11s,12r)-4-hydroxy-1,4-dimethyl-12-[(2s)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(1s,3r,11r,12r,13s,14s,19s)-12-hydroxy-1,11,14,18,18-pentamethyl-7-oxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicos-5(9)-en-8-one
(1r,3ar,5ar,6r,7s,9as,11ar)-7-hydroxy-1-[(2s)-1-hydroxypropan-2-yl]-3a,6,9a,11a-tetramethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-6-carbaldehyde
5-[5-(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)-3-methylpent-2-en-1-yl]-4-(hydroxymethyl)-5h-furan-2-one
(2r)-2-amino-n,3-dihydroxy-n-[(14s)-14-methyl-3,10-dioxohexadecyl]propanamide
4-{6-hydroxy-7,7,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}pentanal
(1's,2r,4's,6'r,9's,10'r,13'r)-5',5',9'-trimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-6'-yl (2z)-2-methylbut-2-enoate
(2s,3s)-3-(methoxycarbonyl)-2-tetradecylpentanedioic acid
(1s,2r,5r,7s,9s,10s,12r,13s,16s)-10-hydroxy-16-isopropyl-1,5,9,13-tetramethyl-6-oxapentacyclo[10.7.0.0²,⁹.0⁵,⁷.0¹³,¹⁷]nonadec-17-en-8-one
(6e,10s,14e)-17-(furan-3-yl)-2,6,10,14-tetramethylheptadeca-6,14-diene-4,12-dione
(4s,6e,8e,10s,11e,14e,16r)-4,6,8,10,12,14,16-heptamethyloctadeca-6,8,11,14-tetraene-3,5,13-trione
(1s,3r,6r,8r,11s,12s,14r,15s,16r)-12,16-dimethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
4-[(1r)-2-[(1r,4ar,4bs,8as,10as)-4b,8,8,10a-tetramethyl-2-methylidene-decahydrophenanthren-1-yl]-1-hydroxyethyl]-5h-furan-2-one
(3r,3as,6r,7as)-6-[(2r)-4-[(1s,5r)-2-acetyl-5-methylcyclopent-2-en-1-yl]butan-2-yl]-3-isopropyl-7a-methyl-hexahydroindene-2,5-dione
(1r,3r,4r,6r,7s,8e,11s,12r)-3,6-dihydroxy-1,4-dimethyl-12-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]tricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(17e)-18-(2h-1,3-benzodioxol-5-yl)octadec-17-en-2-one
(1s,3e,5r,7e,11e)-1-(furan-3-yl)-4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraene-1,5-diol
(7r,8as,9r,10ar)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
n-[(1s)-1-[(1s,3br,5as,7s,9as,9bs,11ar)-9a,11a-dimethyl-7-(methylamino)-1h,2h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide
(1s,3r,6r,7s,9e,13s,15r,16s)-3,15-dimethyl-6-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-12-oxatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadec-9-ene-13,15-diol
(1r,3ar,5ar,6r,7r,9as,11ar)-7-hydroxy-1-[(2s)-1-hydroxypropan-2-yl]-3a,6,9a,11a-tetramethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-6-carbaldehyde
(2s,3s,4e,6e)-7-[(1as,2ar,3s,4r,6ar,7ar)-4-[(2z)-but-2-en-2-yl]-5,7a-dimethyl-1ah,2h,2ah,3h,4h,6ah,7h-naphtho[2,3-b]oxiren-3-yl]-2,4-dimethylhepta-4,6-diene-1,3-diol
1-methyl-5,7-diphenyl-6-(3,4,5,6-tetrahydropyridin-2-yl)-octahydro-2h-quinoline
13-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-3-one
(2s)-2-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]propanoic acid
2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
(6r,7e,16z)-24-methylpentacosa-7,16-dien-2,4-diyne-1,6-diol
(1r,4as,4br,6as,10as,10br,12s,12as)-12-hydroxy-4b,7,7,10a,12a-pentamethyl-1,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-1,2-dicarbaldehyde
(1s,3r,6s,8s,11s,12s,14r,15s,16r)-12,16-dimethyl-6-(methylamino)-15-[(1s)-1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
(1r,3z,7z,11s,12r,15s)-12-formyl-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7-diene-15-carboxylic acid
9a,11a-dimethyl-1-(5-methylhex-3-en-2-yl)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-diol
n-{1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}ethanimidic acid
(1's,2s,3s,3'r,5r,7'r,10'r,11'r)-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecan]-13'-en-12'-one
2-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
(2s,3s,3as,5as,9bs)-3-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
1-(furan-3-yl)-4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraene-1,5-diol
4-[(1r)-2-[(1r,4ar,4bs,10as)-4b,8,8,10a-tetramethyl-2-methylidene-decahydrophenanthren-1-yl]-1-hydroxyethyl]-5h-furan-2-one
4-[(1r)-1-methoxyethyl]-5-methyl-2-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzene-1,3-diol
(3r,3as,6r,7as)-6-[4-(2-acetyl-5-methylcyclopent-2-en-1-yl)butan-2-yl]-3-isopropyl-7a-methyl-hexahydroindene-2,5-dione
(1s,3r,6r,7s,9e,13r,15r,16r)-3,15-dimethyl-6-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-12-oxatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadec-9-ene-13,15-diol
(4r,6r)-4-hydroxy-4,6-dimethyl-6-[(10e)-12-phenyldodec-10-en-1-yl]oxan-2-one
(5r)-5-[(2e)-5-[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-en-1-yl]-4-(hydroxymethyl)-5h-furan-2-one
(5as,5br,7as,11as,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-3-one
(2s,3s,4e,6e)-7-[(1as,2ar,3s,4r,6ar,7ar)-4-[(2e)-but-2-en-2-yl]-5,7a-dimethyl-1ah,2h,2ah,3h,4h,6ah,7h-naphtho[2,3-b]oxiren-3-yl]-2,4-dimethylhepta-4,6-diene-1,3-diol
(1r,3e,7e,11s,12r,15s)-12-formyl-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7-diene-15-carboxylic acid
7-hydroxy-1-(1-hydroxypropan-2-yl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthrene-6-carbaldehyde
(2s,3s,4e,6e)-7-[(1ar,2r,3s,3as,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-1a,6-dimethyl-2h,3h,3ah,4h,7h,7ah,7bh-naphtho[1,2-b]oxiren-3-yl]-2,4-dimethylhepta-4,6-diene-1,3-diol
(2r,3r,4r,5r)-4-{[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methoxy}hexane-1,2,3,5,6-pentol
(2s,3r,4s,5r,6r)-2-({2-[(2r,5s,6r,7r,10s)-7-hydroxy-6,10-dimethylspiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
4-(1-methoxyethyl)-5-methyl-2-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzene-1,3-diol
(1'r,2r,4r,5's)-6,6,6',6',8,8-hexamethyl-4-(2-methylpropyl)-3,4-dihydrospiro[1-benzopyran-2,2'-bicyclo[3.1.1]heptane]-5,7-dione
(1s,3e,7e,11s,15s)-12-(hydroxymethyl)-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7,12-triene-15-carboxylic acid
12,16-dimethyl-6-(methylamino)-15-[1-(methylamino)ethyl]-7-methylidenepentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-14-ol
2-[(2-{7-hydroxy-6,10-dimethylspiro[4.5]decan-2-yl}propan-2-yl)oxy]-6-methyloxane-3,4,5-triol
(3r,3as,6r,7as)-6-[(2r)-4-[(1r,5r)-2-acetyl-5-methylcyclopent-2-en-1-yl]butan-2-yl]-3-isopropyl-7a-methyl-hexahydroindene-2,5-dione
(2s,3r,4s,5r,6r)-2-({2-[(2r,5s,6s,7s,10s)-7-hydroxy-6,10-dimethylspiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
4,8-dimethyl-15-(4-methylpent-3-en-1-yl)spiro[bicyclo[9.3.1]pentadecane-12,2'-oxirane]-3,7-diene-15-carboxylic acid
3,6-dihydroxy-1,4-dimethyl-12-(6-methylhepta-3,5-dien-2-yl)tricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(1r,3s,4r,7r,8e,11s,12r)-4-hydroxy-1,4-dimethyl-12-[(2s)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(2r)-2-[(2s)-1-methoxy-1-oxohexadecan-2-yl]butanedioic acid
(7s,8ar,9r,10ar)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
(1r,3s,4r,8e)-4-hydroxy-1,4-dimethyl-12-[(2s)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.0³,⁷]tetradec-8-ene-8-carbaldehyde
(1s,3r)-2,2-dimethyl-4-methylidene-3-[(3e,7e)-3,8,12-trimethyltrideca-3,7,11-trien-1-yl]cyclohexyl formate
4-[(7e)-4,8-dimethyl-10-(2,6,6-trimethylcyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5-hydroxy-5h-furan-2-one
4-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]hexane-1,2,3,5,6-pentol
(1r,3e,7e,11r,12s,15s)-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)spiro[bicyclo[9.3.1]pentadecane-12,2'-oxirane]-3,7-diene-15-carboxylic acid
(15e,17e)-9,10,12,13-tetrahydroxyhenicosa-15,17-dienoic acid
(2s,3s,3ar,5as,9as,9br)-3-[(2r)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
3,15-dimethyl-6-(6-methylhepta-3,5-dien-2-yl)-12-oxatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadec-9-ene-13,15-diol
n-[(1s,3as,3bs,5ar,9ar,9bs,11as)-1-[(1r)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]carboximidic acid
C24H38N2O2 (386.29331279999997)
(2r,3r,3as,5ar,9ar,9bs)-3-[(2r)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
3-[2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
1-hydroxy-5b,8,8,11a,13a-pentamethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-chryseno[1,2-c]furan-13-one
(7s,8as,9s,10ar)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
12-(hydroxymethyl)-4,8-dimethyl-15-(4-methylpent-3-en-1-yl)bicyclo[9.3.1]pentadeca-3,7,12-triene-15-carboxylic acid
5',5',9'-trimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-6'-yl 2-methylbut-2-enoate
(2s)-2-amino-n,3-dihydroxy-n-(15-methyl-3,10-dioxohexadecyl)propanamide
4-[2-(4b,8,8,10a-tetramethyl-2-methylidene-decahydrophenanthren-1-yl)-1-hydroxyethyl]-5h-furan-2-one
2-ethyl-2-hydroxy-6-isopropyl-3,5-dimethyloxan-4-yl 3-hydroxy-2,4-dimethyl-5-oxoheptanoate
13-hydroxy-5b,8,8,11a,13a-pentamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-1-one
(2s,3s,3as,5as,9as,9bs)-3-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalene-2-carbaldehyde
17-(furan-3-yl)-2,6,10,14-tetramethylheptadeca-6,14-diene-4,12-dione
5',9'-dimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-5'-ylmethyl 2-methylbut-2-enoate
4-[(3e,7e)-4,8-dimethyl-10-(2,6,6-trimethylcyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5-hydroxy-5h-furan-2-one
(7r,8as,9r,10as)-7-isopropyl-2,2,4,4,10a-pentamethyl-9-(2-methylpropyl)-7,8,8a,9-tetrahydroxanthene-1,3-dione
(8r,13r,15s)-13-ethenyl-11-ethyl-8-hydroxy-15-methoxy-11-azahexacyclo[7.6.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁶]octadecane-4-carboximidic acid
5,9-dimethyl-15-[(2-methylbut-2-en-1-yl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
n-[(1s,3as,3bs,5ar,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]carboximidic acid
C24H38N2O2 (386.29331279999997)